홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

2-Methyltetrahydrofuran → 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2-yl dibenzylcarbamate

HRID 1518653
노트
인쇄 미리보기

반응식

HRID 1518653 반응식
[CH:1]1[CH:2]=[C:3]([N:9]2[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][CH2:17][CH2:18][O:19][C:20]3[CH:21]=[CH:22][C:23]4[CH2:30][CH2:29][C:27](=[O:28])[NH:26][C:24]=4[CH:25]=3)[CH2:11][CH2:10]2)[C:4]([Cl:8])=[C:5]([Cl:7])[CH:6]=1.[CH2:31]([N:38]([CH2:42][C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1)[C:39](Cl)=[O:40])[C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1.CC1CCCO1>C(OCC)(=O)C.O>[CH2:42]([N:38]([CH2:31][C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1)[C:39](=[O:40])[O:28][C:27]1[CH2:29][CH2:30][C:23]2[C:24](=[CH:25][C:20]([O:19][CH2:18][CH2:17][CH2:16][CH2:15][N:12]3[CH2:13][CH2:14][N:9]([C:3]4[CH:2]=[CH:1][CH:6]=[C:5]([Cl:7])[C:4]=4[Cl:8])[CH2:10][CH2:11]3)=[CH:21][CH:22]=2)[N:26]=1)[C:43]1[CH:44]=[CH:45][CH:46]=[CH:47][CH:48]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 73012-MethyltetrahydrofuranHCID 60795AripiprazoleHCID 12712012Carbamic chloride, bis(phenylmethyl)-

생성물 1

HCID 565969567-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2-yl dibenzylcarbamate

시약·촉매·용매 2

HCID 962Water용매
HCID 8857
Ethyl Acetate
용매

실험 절차

A mixture of aripiprazole (1.5 g, 3.3 mmol), dibenzylcarbamoyl chloride (1.74 g, 6.7 mmol) silver carbonate (3.75 g, 13.4 mmol) and 2-methyltetrahydrofuran (30 mL) was heated at reflux for 4 days. The reaction mixture was cooled, diluted with ethyl acetate and water, and then filtered through celite. The organic phase was separated, dried over MgSO4 and evaporated. The residue obtained was further purified on silica eluting with ethyl acetate/tetrahydrofuran to give after evaporation of the major product containing fractions, Compound-80 (1.02 g) was a yellow oil.

후처리

  1. temperaturewas heated
  2. temperatureat reflux for 4 days
  3. temperatureThe reaction mixture was cooled
  4. filtrationfiltered through celite
  5. customThe organic phase was separated
  6. dry with materialdried over MgSO4
  7. customevaporated
  8. customThe residue obtained
  9. customwas further purified on silica eluting with ethyl acetate/tetrahydrofuran
  10. customto give
  11. customafter evaporation of the major product
  12. additioncontaining fractions, Compound-80 (1.02 g)

출처 및 근거

ORD 기록
ord-218fe1e14185492984f2870112c42049
출처 데이터셋
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09072788B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트